Inventor · disambiguated record
David Lynch
Also filed as: LYNCH DAVID H · LYNCH DAVID HASKETT
7 granted patents·9 pending applications·135 citations·filing 1990–2010
87Inventor score
Top patents by PatentIndex Score
16 records- 0190US7771958B2Method for predicting response to epidermal growth factor receptor-directed therapyAMGEN INC·Filed 2006·Granted Aug 10, 2010·12 cites·14 claims
- 0279US5229115AAdoptive immunotherapy with interleukin-7IMMUNEX CORP·Filed 1990·Granted Jul 20, 1993·63 cites·31 claims
- 0378US7361330B2Methods of using flt3-ligand in the treatment of fibrosarcomaIMMUNEX CORP·Filed 2002·Granted Apr 22, 2008·5 cites·16 claims
- 0469US5830469AFas antagonists and uses thereofIMMUNEX CORP·Filed 1995·Granted Nov 3, 1998·24 cites·28 claims
- 0568US7150992B1Methods of preparing dendritic cells with flt3-ligand and antigenINNUNEX CORP·Filed 2000·Granted Dec 19, 2006·4 cites·5 claims
- 0668US2006292166A1Vaccine composition comprising Flt3-ligandIMMUNEX CORP·Filed 2006·Application pending·0 cites
- 0768US2009075886A1Dendritic cell stimulatory factorIMMUNEX CORP·Filed 2008·Application pending·0 cites
- 0861US2003165531A1Flt3-ligand as a vaccine adjuvantIMMUNEX CORP·Filed 2003·Application pending·0 cites
- 0961US2004037845A1Use of flt3-ligand in the treatment of infectionFiled 2003·Application pending·0 cites
- 1056US2004132097A1Method for predicting response to epidermal growth factor receptor-directed therapyFiled 2003·Application pending·0 cites
- 1154US5620889AHuman anti-Fas IgG1 monoclonal antibodiesIMMUNEX CORP·Filed 1994·Granted Apr 15, 1997·18 cites·25 claims
- 1254US2010279323A1Method for predicting response to epidermal growth factor receptor-directed therapyAMGEN INC·Filed 2010·Application pending·0 cites
- 1347US6015559AFas antagonistsIMMUNEX CORP·Filed 1998·Granted Jan 18, 2000·9 cites·17 claims
- 1444US2004247563A1Method of enhancing lymphocyte-mediated immune responsesFiled 2001·Application pending·0 cites
- 1541US2004131587A1Method for treatment of tumors using combination therapyFiled 2003·Application pending·0 cites
- 1629US2002034517A1Dendritic cell stimulatory factorFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Lynch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →